Wellgistics Health adopts XRP for payments and reserves

TAMPA, FLORIDA - Wellgistics Health, Inc. (NASDAQ:WGRX), a pharmaceutical distribution and healthcare infrastructure firm with a market capitalization of $226 million, has announced its initiative to implement XRP, a blockchain-based digital asset, for treasury reserves and real-time payments. According to InvestingPro data, the company generated revenue of $18.1 million in the last twelve months while maintaining a GOOD overall financial health score. This move, aimed at enhancing transaction speed, reducing costs, and increasing transparency, positions Wellgistics as one of the first in the healthcare industry to utilize XRP in such a capacity.

Supported by a $50 million Equity Line of Credit, Wellgistics Health’s initiative is expected to streamline financial operations within its national healthcare network. Trading at $4.32 per share, the company has shown strong momentum with a 13.4% return over the past six months, though InvestingPro analysis indicates the stock may be currently overvalued. The use of XRP promises transaction settlements in seconds and notably lower transfer costs compared to traditional banking methods. These improvements are anticipated to benefit pharmacies, suppliers, and manufacturers connected through the Wellgistics platform.

Brian Norton, CEO of Wellgistics Health, emphasized the company’s commitment to innovation by bypassing outdated systems and intermediaries. He stated that the blockchain-enabled payment system is a step forward in revolutionizing healthcare delivery by prioritizing efficiency and control.

The initiative will enable features such as real-time settlements, smart rebates based on accurate data, and XRP-backed credit lines to support independent pharmacies. Additionally, it will facilitate global vendor payouts with minimal foreign transaction fees and provide a compliance layer for regulatory reporting.

Mark DiSiena, CFO of Wellgistics Health, expressed confidence that the XRP-powered infrastructure will allow the company to operate more efficiently compared to its competitors.

The adoption of XRP by Wellgistics Health coincides with broader institutional interest in the digital asset. Upcoming XRP futures contracts by the CME Group, Mastercard’s recognition of XRP for cross-border payments, Ripple’s acquisition of Hidden Road, and Ripple’s regulatory licensing in Dubai, along with new payment corridors in Brazil and Portugal, showcase the growing momentum of XRP in the financial landscape.

Wellgistics Health aims to leverage this momentum to stay ahead in the intersection of healthcare and fintech. The company operates an integrated platform connecting manufacturers to over 6,000 independent pharmacies, focusing on seamless medication distribution and patient-centric fulfillment.

The information in this article is based on a press release statement from Wellgistics Health, Inc. Investors seeking deeper insights into Wellgistics Health’s financial metrics and growth potential can access additional InvestingPro Tips, including detailed analysis of the company’s profit margins, debt levels, and market positioning.

In other recent news, Wellgistics Health, Inc. has announced several significant developments. The company has converted $1.5 million of debt into 333,333 shares of common stock, a move involving CEO Brian Norton, who has committed to a 12-month lock-up agreement on these shares. This conversion reflects Norton’s confidence in the company’s strategic direction. Additionally, Wellgistics Health has acquired Peek Healthcare Technologies, Inc., aiming to enhance its digital healthcare ecosystem and improve prescription pricing transparency for consumers. Peek will continue to operate as a wholly-owned subsidiary, offering expanded resources and strategic relationships. In another development, Wellgistics Health has partnered with Protega Pharmaceuticals to distribute ROXYBOND™, an FDA-approved abuse-deterrent opioid medication. This partnership will focus on enhancing pharmacist education and improving patient access to abuse-deterrent pain management options. These recent developments highlight Wellgistics Health’s ongoing efforts to expand its services and strengthen its position in the healthcare technology sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.